Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spectrum names new chief medical officer

This article was originally published in Scrip

Executive Summary

Spectrum Pharmaceuticals, a biotechnology company focused on hematology and oncology, has appointed Lee Allen chief medical officer. Prior to joining Henderson, Nevada-based Spectrum, Dr Allen served as chief medical officer at AMAG Pharmaceuticals. He will be responsible for the company's product pipeline and will report to Ken Keller, Spectrum's executive vice-president and chief operating officer. Additionally, Spectrum has appointed Dr Steve Fruchtman senior vice-president, hematology and oncology R&D, effective march 18 2013. Dr Fruchtman previously served as chief medical officer at Spectrum and will report to Dr Allen.

Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC020778

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel